Clinical Trial Update: Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating BV100 with low-dose Polymyxin B versus Colistin with high-dose ampicillin/sulbactam for hospital-acquired and ventilator-associated pne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• Ampicillin-sulbactam (Ampicillin-sulbactam)
• BV100
• Colistin (colistin)
• POLYMYXIN B (POLYMYXIN B SULFATE)

Snippet

Sponsor: BioVersys SAS | Conditions: Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP) | Phase 3 | Status: NOT_YET_RECRUITING